全文获取类型
收费全文 | 56266篇 |
免费 | 4036篇 |
国内免费 | 663篇 |
专业分类
耳鼻咽喉 | 1114篇 |
儿科学 | 820篇 |
妇产科学 | 1039篇 |
基础医学 | 8591篇 |
口腔科学 | 1238篇 |
临床医学 | 4927篇 |
内科学 | 11697篇 |
皮肤病学 | 1829篇 |
神经病学 | 4114篇 |
特种医学 | 3095篇 |
外科学 | 7304篇 |
综合类 | 654篇 |
现状与发展 | 3篇 |
一般理论 | 23篇 |
预防医学 | 2355篇 |
眼科学 | 1366篇 |
药学 | 5118篇 |
中国医学 | 682篇 |
肿瘤学 | 4996篇 |
出版年
2023年 | 399篇 |
2022年 | 1213篇 |
2021年 | 1956篇 |
2020年 | 1004篇 |
2019年 | 1489篇 |
2018年 | 1751篇 |
2017年 | 1319篇 |
2016年 | 1839篇 |
2015年 | 2479篇 |
2014年 | 2780篇 |
2013年 | 3262篇 |
2012年 | 4756篇 |
2011年 | 4662篇 |
2010年 | 2821篇 |
2009年 | 2324篇 |
2008年 | 3286篇 |
2007年 | 3025篇 |
2006年 | 2684篇 |
2005年 | 2573篇 |
2004年 | 2130篇 |
2003年 | 1984篇 |
2002年 | 1752篇 |
2001年 | 1164篇 |
2000年 | 1072篇 |
1999年 | 947篇 |
1998年 | 383篇 |
1997年 | 350篇 |
1996年 | 283篇 |
1995年 | 237篇 |
1994年 | 217篇 |
1993年 | 162篇 |
1992年 | 413篇 |
1991年 | 360篇 |
1990年 | 375篇 |
1989年 | 353篇 |
1988年 | 333篇 |
1987年 | 274篇 |
1986年 | 257篇 |
1985年 | 223篇 |
1984年 | 183篇 |
1983年 | 149篇 |
1982年 | 107篇 |
1981年 | 95篇 |
1980年 | 92篇 |
1979年 | 176篇 |
1978年 | 119篇 |
1977年 | 92篇 |
1975年 | 111篇 |
1972年 | 88篇 |
1971年 | 88篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
991.
We report a patient with progressive supranuclear palsy (PSP) with his serial photographs before the onset of ocular symptoms and after the onset with two year intervals. These photographs show his progressive eyeball deviations toward complete exotropia. There were no effective voluntary eyeball movements, Bell''s phenomenon, doll''s eye movements, and vestibulo-ocular reflexes. These signs indicate the involvement of the oculomotor nuclear complex by the disease. We suggest that PSP may cause not only ''supranuclear'' but also ''nuclear'' complete ophthalmoplegia with exodeviation of the eyes. 相似文献
992.
993.
Dong Y. Kim Kyung R. Sung Sung Y. Kang Jung W. Cho Kyoung S. Lee Seong B. Park Soon T. Kim Michael S. Kook 《Acta ophthalmologica. Supplement》2011,89(5):435-441
Purpose: To evaluate the basic characteristics and reproducibility of anterior chamber angle (ACA) measurements determined by anterior‐segment optical coherence tomography (AS‐OCT) in open‐angle and primary angle closure suspect (PACS) patients. Methods: Thirty‐nine open‐angle and 18 PACS patients were imaged for ACA by AS‐OCT. Subjects underwent imaging of the nasal, temporal and inferior ACA under conditions of constant light, and darkness. For analysis, we used three ACA parameters handled by the Visante OCT software: angle opening distance at 500 μm (AOD500), trabecular‐iris space area at 500 μm (TISA500) and angle recess area at 500 μm (ARA500). For determination of inter‐session reproducibility, a single well‐trained operator (D.Y.K.) scanned all patients at two different visits. For determination of inter‐operator variability, a second operator (S.B.P.) acquired another set of images independently. Three sets of images were acquired at least 24 hour apart. Results: All parameters were significantly different when measured both in light and darkness, and in the nasal and temporal quadrants. There were no significant differences between the left and right eyes in the three ACA parameters in all quadrants. The temporal angle was wider than the nasal and inferior angles. All parameters of the nasal, temporal angles had excellent inter‐session and inter‐operator reproducibility [intra‐class correlation coefficient (ICC) 0.796–0.981], but these values were slightly lower for inferior angle measurements (ICC 0.662–0.892) in both open‐angle and PACS groups. Conclusion: AS‐OCT provides quantitative and reproducible assessment of ACA. Reproducibility was lower in the inferior angle compared with the nasal and temporal angles, perhaps because of variable placement of the scleral spur. 相似文献
994.
Moo‐Kon Song Joo‐Seop Chung Young‐Don Joo Yang‐Soo Kim Sung‐Hyun Kim Young‐Mi Seol Ho‐Jin Shin Young‐Jin Choi Goon‐Jae Cho 《European journal of haematology》2009,83(1):72-78
Immunosuppressive therapy (IST) has provided an alternative treatment option for cure of aplastic anemia patients who cannot receive bone marrow transplantation. Although there have been many recent studies on the efficacy of antithymoglobulin (ATG) combined with cyclosporine A (CsA), there is no data on the correlation between the variability of CsA levels and the response to IST. Therefore, we retrospectively assessed the factors associated with IST efficacy in patients with acquired severe aplastic anemia (SAA). Sixty‐six patients were treated with ATG combined with CsA for 6 months. In the response group, the CsA levels were increased rapidly to more than 200 ng/mL within the first 2 wk after starting the IST. However, the non‐response group had a pattern of slower increase of the CsA levels. The CsA levels, during the first and second week of treatment with IST, were significantly different in the responders and non‐responders. The factors predictive of response to IST and survival were analyzed. The univariate analysis showed that a younger age at the initiation of IST, a high absolute neutrophil count prior to starting IST, a short interval between the diagnosis and initiation of IST, and high CsA levels during the first and second week of IST treatment were positively associated with the response rate and overall survival. The multivariate analysis showed that these four factors were independent factors associated with a longer patient survival. A high response rate was associated with a short interval between diagnosis and initiation of IST as well as high CsA levels during the first and second week of IST. Therefore, early intensification of CsA levels might improve patient outcome. 相似文献
995.
C.P. Chow MBBS MRCPCH H.K. Ho MBBS MRCP G.C.F. Chan MD FRCPCH S.Y. Ha MBBS FRCPCH 《Pediatric blood & cancer》2009,52(3):415-417
Rosai–Dorfman disease (RDD) is a rare entity of non‐Langerhans cell histiocytoses (non‐LCH) which usually presents with bilateral painless cervical lymphadenopathy. We describe a neonate with RDD who presented with anemia, thrombocytopenia and hepatomegaly. He recovered spontaneously with conservative management. This represents an atypical presentation of RDD. Conservative management with close monitoring can be adopted for some with systemic involvement. Pediatr Blood Cancer 2009;52:415–417. © 2008 Wiley‐Liss, Inc. 相似文献
996.
Active immunization against de novo hepatitis B virus infection in pediatric patients after liver transplantation 总被引:3,自引:0,他引:3
Chang SH Suh KS Yi NJ Choi SH Lee HJ Seo JK Lee KU 《Hepatology (Baltimore, Md.)》2003,37(6):1329-1334
The shortage of donor organs occasionally mandates the use of hepatic allografts from anti-HBc (+) donors. HBIG and/or lamivudine are recommended for the prevention of de novo HBV infection in naive patients, but there are attendant problems, such as mutant strain emergence and high cost. Active immunization presents a better alternative than the use of HBIG or lamivudine, if it can be proven to be effective. Accordingly, we investigated the outcome of HBV vaccination in pediatric hepatic transplant recipients. Between July 1999 and October 2001, 19 pediatric recipients were administered HBV vaccinations after liver transplantation at Seoul National University Hospital. Nine patients received a graft from anti-HBc (+) donors and 10 from anti-HBc (-) donors. When steroid was withdrawn, recombinant HBV vaccine was administered. The median follow-up period after vaccination was 10.0 +/- 5.2 months. Seventeen of the 19 patients showed a positive response to vaccination. In 9 patients who received grafts from anti-HBc (+) donors, 2 patients showed no response, 4 patients low response (peak HBsAb titer <1,000 IU/L), and 3 patients high response (peak HBsAb titer >/=1,000 IU/L). De novo HBV infection developed in 1 of 2 patients who showed no response to vaccination. In 10 patients who received grafts from anti-HBc (-) donors, 5 showed a low response and 5 a high response. In conclusion, HBV vaccination in pediatric patients after liver transplantation appeared to exhibit some effectiveness at protecting young children that received a graft from anti-HBc (+) donors from de novo HBV infection. 相似文献
997.
Mun Su Kang Dong Il Park Jung Won Yun Se Yong Oh Tae Woo Yoo Jung Ho Park Hong Joo Kim Yong Kyun Cho Chong Il Sohn Woo Kyu Jeon Byung Ik Kim 《Taehan Sohwagi Hakhoe chi》2006,47(1):30-36
BACKGROUND/AIMS: Antibiotic resistance and poor compliance are the main causes of Helicobacter pylori (H. pylori) eradication failure. This study evaluated the eradication rate, tolerability, and compliance of levofloxacin- azithromycin combined triple therapy for H. pylori eradication. METHODS: 1) First-line eradication: A total of 78 H. pylori-positive patients were enrolled. Seventeen military men in Armed Forces Capital Hospital were treated with 7 days of levofloxacin-azithromycin combined triple therapy (omeprazole 20 mg bid, levofloxacin 500 mg od, and azithromycin 500 mg od), and 61 patients in Kangbuk Samsung Hospital were treated with standard PPI-based triple therapy (omeprazole 20 mg bid, amoxicillin 1.0 g bid, and clarithromycin 500 mg bid) for 7 days. 2) Second-line eradication: A consecutive series of 59 patients who failed H. pylori eradication with standard PPI-based triple therapy in Kangbuk Samsung Hospital were randomized to two groups. Thirty patients were retreated with 7 days of bismuth-based quadruple therapy (omeprazole 20 mg bid, bismuth 120 mg qid, metronidazole 500 mg tid, and tetracycline 500 mg qid), and remaining 29 patients were retreated with levofloxacin-azithromycin combined triple therapy. Patient's compliance and tolerability were evaluated at the end of treatment. The status of H. pylori infection was assessed 8 weeks later then. The successful eradication of H. pylori was defined as negative results from histology and CLO test, or 13C-urea breath test. RESULTS: First-line eradication rate of levofloxacin-azithromycin triple therapy was lower than that of standard PPI-based triple therapy, but there was no statistically significant difference (70.6% vs. 80.3%, p=0.390). Second-line eradication rate of levofloxacin-azithromycin combined triple therapy was significantly lower than that of bismuth-based quadruple therapy (ITT/PP 65.5%/73.1% vs. 90%/90%, p<0.0001). The compliances of all patients were more than 85%. Two of patients with levofloxacin-azithromycin combined triple therapy complained self-limiting side effects (mild dizziness; mild insomnia with general weakness). CONCLUSIONS: Levofloxacin-azithromycin combined triple therapy should not be recommended as the first-line or second-line H. pylori eradication regimen in Korea. 相似文献
998.
The effects of rosiglitazone and metformin on the plasma concentrations of resistin in patients with type 2 diabetes mellitus 总被引:8,自引:0,他引:8
Jung HS Youn BS Cho YM Yu KY Park HJ Shin CS Kim SY Lee HK Park KS 《Metabolism: clinical and experimental》2005,54(3):314-320
Resistin is a protein secreted from adipose tissue that is thought to play a role in insulin sensitivity. We examined the effects of rosiglitazone and metformin on the plasma resistin levels in individuals with type 2 diabetes mellitus. Patients with type 2 diabetes mellitus who showed poor glycemic control with glimepiride (4 mg/d) were randomized to rosiglitazone (4 mg/d) and metformin (500 mg bid) treatment groups. All subjects continued glimepiride treatment as well. The plasma concentrations of resistin were measured at baseline and at 6 months of treatment for both groups. The anthropometric parameters, fasting plasma glucose, HbA1c, total cholesterol, triglyceride, high-density lipoprotein cholesterol, free fatty acids, and adiponectin concentrations were also measured. After 6 months of treatment, the reduction in plasma glucose levels was similar between the 2 groups. There were no significant changes in the lipid profiles of either group during the study period. The plasma resistin levels decreased in the rosiglitazone group (2.49 +/- 1.93 vs 1.95 +/- 1.59 ng/ml; P < .05) but increased in the metformin group (2.61 +/- 1.69 vs 5.13 +/- 2.81 ng/ml; P < .05). The plasma adiponectin concentrations were increased in the rosiglitazone group (2.91 +/- 1.46 vs 4.23 +/- 1.77 microg/ml; P < .05) but were unchanged in the metformin group. In summary, rosiglitazone treatment decreased the plasma resistin levels whereas metformin treatment increased them in patients with type 2 diabetes mellitus showing poor glycemic control with sulfonylurea therapy. These results suggest that the observed changes in plasma resistin levels are not the consequences of improved insulin resistance, nor are they consequences of glycemic control. Considering the potential role of resistin in insulin resistance, decrease in resistin levels may contribute to improving insulin action with rosiglitazone treatment. 相似文献
999.
Diego Dantas Almeida Vincent Louis Viala Pedro Gabriel Nachtigall Michael Broe H. Lisle Gibbs Solange Maria de Toledo Serrano Ana Maria Moura-da-Silva Paulo Lee Ho Milton Yutaka Nishiyama-Jr Incio L. M. Junqueira-de-Azevedo 《Proceedings of the National Academy of Sciences of the United States of America》2021,118(20)
1000.
Clinicopathological significance of vascular endothelial growth factor-C and cyclooxygenase-2 in esophageal squamous cell carcinoma 总被引:17,自引:0,他引:17
Byeon JS Jung HY Lee YJ Lee D Lee GH Myung SJ Yang SK Hong WS Kim JH Min YI Kim JS 《Journal of gastroenterology and hepatology》2004,19(6):648-654
BACKGROUND: Vascular endothelial growth factor-C (VEGF-C) is a specific growth factor of lymphatics, which is known to play some role in tumor growth and metastasis to lymph nodes and distant organs in various malignancies. The purpose of the present study was to investigate the expression of VEGF-C in human esophageal squamous cell carcinomas (ESCC) to elucidate its role in tumor progression and lymph node metastasis. Another aim of the study was to investigate the relation between VEGF-C and cyclooxygenase-2 (COX-2) in ESCC. METHODS: The expression of VEGF-C and COX-2 in ESCC was evaluated in 13 endoscopic mucosal resection specimens and in 21 surgical specimens by immunohistochemical staining. Clinical data were obtained from medical records. RESULTS: The degree of VEGF-C expression increased as the depth of primary tumor progressed (r = 0.521, P = 0.002), the stage progressed (r = 0.572, P < 0.001), and the degree of COX-2 expression increased (r = 0.387, P = 0.024). The VEGF-C positive rate was different between early cancers in which regional lymph node metastasis was thought to be absent and advanced cancers in which regional lymph node metastases were confirmed after surgery (20.0% vs 100.0%; P < 0.001). CONCLUSIONS: The VEGF-C expression in ESCC is related to COX-2 expression, and VEGF-C is also associated with the depth of primary tumor, the stage, and probably lymph node metastasis. Thus the investigation of VEGF-C expression in ESCC may assist in management planning. 相似文献